Compound or practice · Supplement

Cat's Claw

An Amazonian anti-inflammatory bark with early joint-pain evidence and immune-modulating caveats.

Overall grade
Grade C
Last revised
1
graded outcome
0
references listed

A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.

1 at grade C — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

  • Joint pain (OA/RA)Evidence grade C

    Small trials

    Smallmixed

What is uncertain

Read off the same rows as above. Nothing here is added that the entry does not itself record.

  • Thin evidence: Joint pain (OA/RA) (grade C).
  • Caution with Immunosuppressants: Immune modulation may oppose the drug.

Interactions

Documented pairings with supplements and medicines. A medicine on this list is a conversation for whoever prescribes it.

  • ImmunosuppressantsCaution

    Immune modulation may oppose the drug.

The evidence in words

What it is

Cat's claw (Uncaria tomentosa) is a South American vine used for inflammation and joint pain.

How it works

Alkaloids and other compounds have anti-inflammatory and immune-modulating activity.

What the evidence shows

Small trials suggest reduced osteoarthritis and rheumatoid-arthritis joint pain; evidence is limited. Its immune modulation warrants caution with immunosuppressants and autoimmune disease.

Safety & interactions

Generally tolerated; caution with immunosuppressants and autoimmune conditions. immunosuppressants — Immune modulation may oppose the drug.

Bottom line

An early-evidence joint anti-inflammatory. Reasonable to trial for OA; mind the immune interactions.

Entries that share this one's tags or conditions.

Sources

This entry lists no references of its own.

Last revised . A grade is this entry's reading of the evidence, not medical advice.